ERK inhibitor synergistic with bufalin induces K562 cells’ apoptosis

WANG Su,ZHANG Xiao-jing,LIU Yun-peng,HOU Ke-zuo,LUO Ying,LIU Shi-zhou
DOI: https://doi.org/10.3321/j.issn:1000-5404.2007.05.007
2007-01-01
Abstract:Objective To observe the synergistic effects of extracellular signal regulated kinase (ERK) inhibitor PD98059 and bufalin on the apoptosis of K562 cells. Methods The percentage of viable cells was determined by trypan blue exclusion. Cell apoptosis was examined by morphology and flow cytometry, and the bcl-2 protein was measured by western blot analysis. Results ERK inhibitor alone inhibited the proliferation of cells, downregulated bcl-2 protein and induced apoptosis of K562 cells; bufalin was proved to have synergistic effect on the PD98059-induced apoptosis, and downregulated bcl-2 protein markedly. Conclusion PD98059 has synergistic effect with bufalin to induce the apoptosis of K562 cells, probably by the mechanism of bcl-2 protein downregulation.
What problem does this paper attempt to address?